Mohsen Rajaeinejad
Overview
Explore the profile of Mohsen Rajaeinejad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hajali M, Karbalaei-Musa H, Arbaghaei M, Rajaeinejad M, Aslani P, Mirzaii-Dizgah I
Asian Pac J Cancer Prev
. 2024 Dec;
25(12):4111-4114.
PMID: 39733398
Objective: Gastrointestinal cancer is one of the most common causes of death worldwide. As there are no clinical symptoms at the beginning of the disease, the diagnosis can be delayed...
2.
Poursheikhani A, Mosallaei M, Heidari M, Rajaeinejad M, Chamanara M, Zoshk M, et al.
Iran J Public Health
. 2024 Oct;
53(9):2090-2102.
PMID: 39429673
Background: Glioblastoma multiforme (GBM) is one of the most invasive types of brain cancer. LncRNAs can be considered a new prognostic and diagnostic biomarker in GBM. This study comprehensively explored...
3.
Tayanloo-Beik A, Eslami A, Sarvari M, Jalaeikhoo H, Rajaeinejad M, Nikandish M, et al.
Oncol Rev
. 2024 Aug;
18:1411736.
PMID: 39091989
The global incidence of cancer is increasing, with estimates suggesting that there will be 26 million new cases and 17 million deaths per year by 2030. Cancer stem cells (CSCs)...
4.
Faraji S, Rajaeinejad M, Bagheri H, Afshar Ardalan M, Moutabian H, Ehsani F, et al.
J Biomed Phys Eng
. 2024 Jul;
14(3):287-298.
PMID: 39027706
Background: Radiotherapy, a highly effective method of radiation-based treating cancers, can reduce the size of tumors and affect healthy tissues. Radiation-induced lymphopenia as a side effect of radiation therapy can...
5.
Mohsenizadeh S, Rajaeinejad M, Khoshfetrat M, Arefizadeh R, Mousavi S, Mosaed R, et al.
Adv Exp Med Biol
. 2024 Jun;
1474():179-199.
PMID: 38842787
Recent advancements in personalized treatments, such as anthracycline chemotherapy, coupled with timely diagnoses, have contributed to a decrease in cancer-specific mortality rates and an improvement in cancer prognosis. Anthracyclines, a...
6.
Arjmand B, Alavi-Moghadam S, Faraji Z, Aghajanpoor-Pasha M, Jalaeikhoo H, Rajaeinejad M, et al.
Adv Exp Med Biol
. 2024 May;
1470:115-128.
PMID: 38811486
Colorectal cancer is a global health concern with high incidence and mortality rates. Conventional treatments like surgery, chemotherapy, and radiation therapy have limitations in improving patient survival rates. Recent research...
7.
Farhadi A, Poursheikhani A, Heidari M, Rajaeinejad M, Mosaed R, Faridfar A, et al.
Pathol Res Pract
. 2024 May;
258:155337.
PMID: 38735276
Background: Inappropriate expressions of various miRNAs have reported in different human malignancies. Evidence suggested that miR-330 may play as both onco-miR and/or tumor suppressor-miR in different cancers. In the present...
8.
Arjmand B, Hamidpour S, Tayanloo-Beik A, Arjmand R, Rezaei-Tavirani M, Aghayan H, et al.
Methods Mol Biol
. 2024 Feb;
2849:215-226.
PMID: 38329617
In oncological research, the function of tumor-infiltrating natural killer (NK) cells in skin carcinoma presents a viable avenue for novel therapeutic methods. NK cells are essential to the body's defense...
9.
Rajaeinejad M, Parhizkar-Roudsari P, Khoshfetrat M, Kazemi-Galougahi M, Mosaed R, Arjmand R, et al.
Cardiovasc Toxicol
. 2024 Feb;
24(2):184-198.
PMID: 38324115
Advancements in cancer treatments have improved survival rates but have also led to increased cardiotoxicities, which can cause adverse cardiovascular events or worsen pre-existing conditions. Herein, cardiotoxicity is a severe...
10.
Tayanloo-Beik A, Roudsari P, Aghayan H, Arjmand R, Rezaei-Tavirani M, Larijani B, et al.
Methods Mol Biol
. 2023 Dec;
2849:253-263.
PMID: 38095836
Cutaneous squamous cell carcinoma (cSCC), a non-melanoma skin cancer that is frequently diagnosed, is distinguished by its propensity for aggressive behavior, frequent poor response to standard therapy, and capacity to...